Smartleaf Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Smartleaf Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Buy	1,416 +28	+2%	+$2.21K	﹤0.01%	1100
2025 Q4	$110K	Buy	1,388 +1,284	+1,235%	+$96.7K	﹤0.01%	1137
2025 Q3	$6.67K	Buy	+104	New	+$5.08K	﹤0.01%	2272
2025 Q2	–	Sell	-131	Closed	-$4.08K	–	2852
2025 Q1	$4.08K	Sell	131 -197	-60%	-$6.45K	﹤0.01%	2259
2024 Q4	$11.5K	Sell	328 -99	-23%	-$3.7K	﹤0.01%	1940
2024 Q3	$17.4K	Buy	427 +368	+624%	+$17.1K	﹤0.01%	1429
2024 Q2	$2.79K	Buy	59 +33	+127%	+$1.35K	﹤0.01%	2083
2024 Q1	$1.16K	Buy	+26	New	+$1.24K	﹤0.01%	1584

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smartleaf Asset Management's IONS Position: Q1 2026 in Review

Smartleaf Asset Management increased its Ionis Pharmaceuticals (IONS) stake by 2% in Q1 2026, buying an estimated $2.21K and bringing the position to 1,416 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Smartleaf Asset Management first reported a position in IONS in Q1 2024 and has held it in 8 quarters since. The position peaked at $110K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Smartleaf Asset Management held 1,416 shares of Ionis Pharmaceuticals worth $103K as of Q1 2026.
Smartleaf Asset Management bought 28 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.21K.
Ionis Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1100 holding.
Smartleaf Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's Ionis Pharmaceuticals position peaked at $110K in Q4 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.